Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells

Ana M. Grau, Pran K. Datta, Jinghuan Zi, Sunil Krishna Halder, R. Daniel Beauchamp

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Nuclear factor kappa B (NF-κB) has been implicated in cancer cell survival. We explored the role of the TGF-β pathway in the regulation of NF-κB in colon cancer cells. TGF-β-1 treatment of the colon adenocarcinoma cell line FET-1, results in an early increase in IκB-α phosphorylation that precedes NF-κB nuclear translocation and DNA binding activity. Activation of the TGF-β type I receptor is required for the TGF-β-mediated activation of NF-κB. No activation of NF-κB is observed in a Smad4 null cell line, SW480, even though TGF-β does result in IκB-α phosphorylation in these cells. Smad4 restores the TGF-β-1-mediated NF-κB activation in SW480 cells. TGF-β-1 treatment fails to activate NF-κB or phosphorylate IκB-α in FET-1 cells expressing the inhibitory Smad, Smad7. Taken together, these results suggest a role for Smad4 in the transcriptional activation of NF-κB, and a direct effect of Smad 7 inhibiting IκB-α phosphorylation rather than through the well-established inhibition of Smad2/3 phosphorylation with subsequent inhibition of the TGF-β pathway.

Original languageEnglish (US)
Pages (from-to)1041-1050
Number of pages10
JournalCellular Signalling
Volume18
Issue number7
DOIs
StatePublished - Jul 1 2006

Fingerprint

Smad Proteins
NF-kappa B
Colonic Neoplasms
Phosphorylation
Cell Line
Null Lymphocytes
Transcriptional Activation
Cell Survival
Colon
Adenocarcinoma
DNA

Keywords

  • Iκβ-α
  • NF-κβ
  • Smad4
  • Smad7
  • TGF-β

ASJC Scopus subject areas

  • Cell Biology

Cite this

Grau, A. M., Datta, P. K., Zi, J., Halder, S. K., & Beauchamp, R. D. (2006). Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells. Cellular Signalling, 18(7), 1041-1050. https://doi.org/10.1016/j.cellsig.2005.08.021

Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells. / Grau, Ana M.; Datta, Pran K.; Zi, Jinghuan; Halder, Sunil Krishna; Beauchamp, R. Daniel.

In: Cellular Signalling, Vol. 18, No. 7, 01.07.2006, p. 1041-1050.

Research output: Contribution to journalArticle

Grau, AM, Datta, PK, Zi, J, Halder, SK & Beauchamp, RD 2006, 'Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells', Cellular Signalling, vol. 18, no. 7, pp. 1041-1050. https://doi.org/10.1016/j.cellsig.2005.08.021
Grau, Ana M. ; Datta, Pran K. ; Zi, Jinghuan ; Halder, Sunil Krishna ; Beauchamp, R. Daniel. / Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells. In: Cellular Signalling. 2006 ; Vol. 18, No. 7. pp. 1041-1050.
@article{ce596482dccd4a168a2a05e55be0d5be,
title = "Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells",
abstract = "Nuclear factor kappa B (NF-κB) has been implicated in cancer cell survival. We explored the role of the TGF-β pathway in the regulation of NF-κB in colon cancer cells. TGF-β-1 treatment of the colon adenocarcinoma cell line FET-1, results in an early increase in IκB-α phosphorylation that precedes NF-κB nuclear translocation and DNA binding activity. Activation of the TGF-β type I receptor is required for the TGF-β-mediated activation of NF-κB. No activation of NF-κB is observed in a Smad4 null cell line, SW480, even though TGF-β does result in IκB-α phosphorylation in these cells. Smad4 restores the TGF-β-1-mediated NF-κB activation in SW480 cells. TGF-β-1 treatment fails to activate NF-κB or phosphorylate IκB-α in FET-1 cells expressing the inhibitory Smad, Smad7. Taken together, these results suggest a role for Smad4 in the transcriptional activation of NF-κB, and a direct effect of Smad 7 inhibiting IκB-α phosphorylation rather than through the well-established inhibition of Smad2/3 phosphorylation with subsequent inhibition of the TGF-β pathway.",
keywords = "Iκβ-α, NF-κβ, Smad4, Smad7, TGF-β",
author = "Grau, {Ana M.} and Datta, {Pran K.} and Jinghuan Zi and Halder, {Sunil Krishna} and Beauchamp, {R. Daniel}",
year = "2006",
month = "7",
day = "1",
doi = "10.1016/j.cellsig.2005.08.021",
language = "English (US)",
volume = "18",
pages = "1041--1050",
journal = "Cellular Signalling",
issn = "0898-6568",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells

AU - Grau, Ana M.

AU - Datta, Pran K.

AU - Zi, Jinghuan

AU - Halder, Sunil Krishna

AU - Beauchamp, R. Daniel

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Nuclear factor kappa B (NF-κB) has been implicated in cancer cell survival. We explored the role of the TGF-β pathway in the regulation of NF-κB in colon cancer cells. TGF-β-1 treatment of the colon adenocarcinoma cell line FET-1, results in an early increase in IκB-α phosphorylation that precedes NF-κB nuclear translocation and DNA binding activity. Activation of the TGF-β type I receptor is required for the TGF-β-mediated activation of NF-κB. No activation of NF-κB is observed in a Smad4 null cell line, SW480, even though TGF-β does result in IκB-α phosphorylation in these cells. Smad4 restores the TGF-β-1-mediated NF-κB activation in SW480 cells. TGF-β-1 treatment fails to activate NF-κB or phosphorylate IκB-α in FET-1 cells expressing the inhibitory Smad, Smad7. Taken together, these results suggest a role for Smad4 in the transcriptional activation of NF-κB, and a direct effect of Smad 7 inhibiting IκB-α phosphorylation rather than through the well-established inhibition of Smad2/3 phosphorylation with subsequent inhibition of the TGF-β pathway.

AB - Nuclear factor kappa B (NF-κB) has been implicated in cancer cell survival. We explored the role of the TGF-β pathway in the regulation of NF-κB in colon cancer cells. TGF-β-1 treatment of the colon adenocarcinoma cell line FET-1, results in an early increase in IκB-α phosphorylation that precedes NF-κB nuclear translocation and DNA binding activity. Activation of the TGF-β type I receptor is required for the TGF-β-mediated activation of NF-κB. No activation of NF-κB is observed in a Smad4 null cell line, SW480, even though TGF-β does result in IκB-α phosphorylation in these cells. Smad4 restores the TGF-β-1-mediated NF-κB activation in SW480 cells. TGF-β-1 treatment fails to activate NF-κB or phosphorylate IκB-α in FET-1 cells expressing the inhibitory Smad, Smad7. Taken together, these results suggest a role for Smad4 in the transcriptional activation of NF-κB, and a direct effect of Smad 7 inhibiting IκB-α phosphorylation rather than through the well-established inhibition of Smad2/3 phosphorylation with subsequent inhibition of the TGF-β pathway.

KW - Iκβ-α

KW - NF-κβ

KW - Smad4

KW - Smad7

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=33645101402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645101402&partnerID=8YFLogxK

U2 - 10.1016/j.cellsig.2005.08.021

DO - 10.1016/j.cellsig.2005.08.021

M3 - Article

C2 - 16288847

AN - SCOPUS:33645101402

VL - 18

SP - 1041

EP - 1050

JO - Cellular Signalling

JF - Cellular Signalling

SN - 0898-6568

IS - 7

ER -